Lord Abbett Health Care R6 (LHCVX)
| Fund Assets | 8.67M |
| Expense Ratio | 0.68% |
| Min. Investment | $0.00 |
| Turnover | 91.00% |
| Dividend (ttm) | 0.08 |
| Dividend Yield | 0.34% |
| Dividend Growth | -23.52% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 2, 2025 |
| Previous Close | 24.46 |
| YTD Return | 7.00% |
| 1-Year Return | 33.49% |
| 5-Year Return | 27.14% |
| 52-Week Low | 18.31 |
| 52-Week High | 24.73 |
| Beta (5Y) | n/a |
| Holdings | 60 |
| Inception Date | Jul 31, 2019 |
About LHCVX
Lord Abbett Health Care Fund Class R6 is a mutual fund that primarily invests in the stocks of companies within the healthcare sector. Its central objective is to provide long-term capital growth by targeting firms engaged in healthcare services, pharmaceuticals, biotechnology, medical devices, and related industries. The fund leverages the expertise of its management team to construct a diversified portfolio with exposure to various healthcare sub-sectors, aiming to benefit from demographic trends, innovation in medical technology, and shifting healthcare regulations. This fund is designed to offer investors targeted access to a sector that plays a critical role in the global economy, impacting everything from patient care and medical research to drug development and healthcare infrastructure. By focusing exclusively on the healthcare industry, the fund serves investors seeking sector-specific diversification within their broader investment portfolios, and it is often used as a tool for capitalizing on both defensive and growth opportunities inherent to the healthcare market.
Performance
LHCVX had a total return of 33.49% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.55%.
Top 10 Holdings
38.34% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 9.06% |
| AstraZeneca PLC | AZN | 4.82% |
| Gilead Sciences, Inc. | GILD | 4.33% |
| Johnson & Johnson | JNJ | 3.25% |
| Nektar Therapeutics | NKTR | 3.23% |
| Natera, Inc. | NTRA | 2.97% |
| Tarsus Pharmaceuticals, Inc. | TARS | 2.88% |
| Guardant Health, Inc. | GH | 2.68% |
| argenx SE | ARGX | 2.61% |
| Novartis AG | NOVN | 2.52% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 2, 2025 | $0.0839 | Dec 2, 2025 |
| Nov 26, 2024 | $0.1097 | Nov 26, 2024 |
| Nov 22, 2022 | $0.0471 | Nov 22, 2022 |
| Nov 23, 2021 | $1.4724 | Nov 23, 2021 |
| Nov 24, 2020 | $2.3345 | Nov 24, 2020 |
| Nov 21, 2019 | $0.0104 | Nov 21, 2019 |